Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | GLA | P06280 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.39 |
| ▸ | USP2 | O75604 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | CA12 | O43570 | 2/20 | 0.38 |
| ▸ | CA7 | P43166 | 1/20 | 0.38 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18770758 | 0.98 | KMT2A (0.51) | KMT2AMEN1GLAKDM4EALDH1A1 | |
| SCHEMBL6200 | 0.98 | KMT2A (0.51) | KMT2AMEN1GLAKDM4EALDH1A1 | |
| Hydrochloric Acid SCHEMBL5962066 | 0.96 | GLA (0.52) | KMT2AMEN1GLAKDM4EALDH1A1 | |
| Water SCHEMBL659931 | 0.96 | KMT2A (0.50) | KMT2AMEN1GLAKDM4EALDH1A1 | |
| Water SCHEMBL1157088 | 0.96 | KMT2A (0.50) | KMT2AMEN1GLAKDM4EALDH1A1 | |
| SCHEMBL5492635 | 0.96 | KMT2A (0.50) | KMT2AMEN1GLAKDM4EALDH1A1 | |
| Ammonia Solution, Strong SCHEMBL1509056 | 0.96 | KMT2A (0.50) | KMT2AMEN1GLAKDM4EALDH1A1 | |
| Water SCHEMBL108075 | 0.96 | KMT2A (0.50) | KMT2AMEN1GLAKDM4EALDH1A1 | |
| SCHEMBL29027430 | 0.96 | KMT2A (0.50) | KMT2AMEN1GLAKDM4EALDH1A1 | |
| SCHEMBL285411 | 0.96 | KMT2A (0.50) | KMT2AMEN1GLAKDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118139435-A | Perovskite solar cell module with buried bottom interface modification and preparation method | 中南大学 | 2024-06-04 | — | — | CN | disclosed |
| US-20210207153-A1 | SYSTEMS AND METHODS FOR EDITING A PLANT GENOME | PIONEER HI-BRED INTERNATIONAL, INC. (US) | 2021-07-08 | — | — | US | disclosed |
| WO-2021067415-A1 | NDUFS2 SUBUNIT KNOCKOUT HUMAN CELL LINE | VIRGINIA TECH INTELLECTUAL PROPERTIES INC. (US) | 2021-04-08 | — | — | WO | disclosed |
| US-9637524-B2 | Proteolysis-resistant capsid of chimeric hepatitis E virus as an oral delivery vector | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2017-05-02 | — | — | US | disclosed |
| EP-2400982-B1 | MULTIPLE ANTIGEN DELIVERY SYSTEM USING HEPATITIS E VIRUS-LIKE PARTICLE | UNIV CALIFORNIA (US) | 2016-05-11 | — | — | EP | disclosed |
| US-20150118319-A1 | PROTEOLYSIS-RESISTANT CAPSID OF CHIMERIC HEPATITIS E VIRUS AS AN ORAL DELIVERY VECTOR | UNIV CALIFORNIA (US) | 2015-04-30 | — | — | US | disclosed |
| US-8906863-B2 | Proteolysis-resistant capsid of chimeric hepatitis E virus as an oral delivery vector | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2014-12-09 | — | — | US | disclosed |
| US-8906862-B2 | Multiple antigen delivery system using hepatitis E virus-like particle | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2014-12-09 | — | — | US | disclosed |
| US-20120301494-A1 | PROTEOLYSIS-RESISTANT CAPSID OF CHIMERIC HEPATITIS E VIRUS AS AN ORAL DELIVERY VECTOR | REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2012-11-29 | — | — | US | disclosed |
| US-20120148517-A1 | Hair Relaxing and Straightening Compositions | INTERNATIONAL FLORA TECHNOLOGIES, LTD. (US) | 2012-06-14 | — | — | US | disclosed |
| EP-0397753-B1 | DETERMINATION OF GENETIC SEX IN RUMINANTS USING Y-CHROMOSOME-SPECIFIC POLYNUCLEOTIDES | ADVANCED RIVERINA HOLDINGS (AU) | 1996-06-12 | — | — | EP | disclosed |
| EP-0618980-A1 | COLORIMETRIC DETERMINATION OF PEROXIDASE AND PEROXIDE | ABBOTT LABORATORIES (US) | 1994-10-12 | — | — | EP | disclosed |
| WO-1993012253-A1 | COLORIMETRIC DETERMINATION OF PEROXIDASE AND PEROXIDE | ABBOTT LABORATORIES (US) | 1993-06-24 | — | — | WO | disclosed |
| EP-0276287-B1 | SEX DETERMINATION IN RUMINANTS USING Y-CHROMOSOME SPECIFIC POLYNUCLEOTIDES | THE AUSTRALIAN NATIONAL UNIVERSITY (AU) | 1993-04-07 | — | — | EP | disclosed |
| EP-0397753-A4 | DETERMINATION OF GENETIC SEX IN RUMINANTS USING Y-CHROMOSOME-SPECIFIC POLYNUCLEOTIDES | — | 1991-06-19 | — | — | EP | disclosed |
| EP-0397753-A1 | DETERMINATION OF GENETIC SEX IN RUMINANTS USING Y-CHROMOSOME-SPECIFIC POLYNUCLEOTIDES. | ADVANCED RIVERINA HOLDINGS (AU) | 1990-11-22 | — | — | EP | disclosed |
| EP-0276287-A4 | SEX DETERMINATION IN RUMINANTS USING Y-CHROMOSOME SPECIFIC POLYNUCLEOTIDES. | UNIV AUSTRALIAN (AU) | 1989-09-19 | — | — | EP | disclosed |
| WO-1989007154-A1 | DETERMINATION OF GENETIC SEX IN RUMINANTS USING Y-CHROMOSOME-SPECIFIC POLYNUCLEOTIDES | ADVANCED RIVERINA HOLDINGS LIMITED (AU) | 1989-08-10 | — | — | WO | disclosed |
| EP-0276287-A1 | SEX DETERMINATION IN RUMINANTS USING Y-CHROMOSOME SPECIFIC POLYNUCLEOTIDES. | UNIV AUSTRALIAN (AU) | 1988-08-03 | — | — | EP | disclosed |
| WO-1988001300-A1 | SEX DETERMINATION IN RUMINANTS USING Y-CHROMOSOME SPECIFIC POLYNUCLEOTIDES | THE AUSTRALIAN NATIONAL UNIVERSITY (AU) | 1988-02-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120148517-A1 | Hair Relaxing and Straightening Compositions | PDE6G, SHH, DNMT3L | KMT2A 268/4885MEN1 863/4885GLA 1584/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.